171 related articles for article (PubMed ID: 21671294)
1. MRI-guided neutron capture therapy by use of a dual gadolinium/boron agent targeted at tumour cells through upregulated low-density lipoprotein transporters.
Geninatti-Crich S; Alberti D; Szabo I; Deagostino A; Toppino A; Barge A; Ballarini F; Bortolussi S; Bruschi P; Protti N; Stella S; Altieri S; Venturello P; Aime S
Chemistry; 2011 Jul; 17(30):8479-86. PubMed ID: 21671294
[TBL] [Abstract][Full Text] [Related]
2. In vivo labeling of B16 melanoma tumor xenograft with a thiol-reactive gadolinium based MRI contrast agent.
Menchise V; Digilio G; Gianolio E; Cittadino E; Catanzaro V; Carrera C; Aime S
Mol Pharm; 2011 Oct; 8(5):1750-6. PubMed ID: 21780833
[TBL] [Abstract][Full Text] [Related]
3. Combination of boron and gadolinium compounds for neutron capture therapy. An in vitro study.
Matsumura A; Zhang T; Nakai K; Endo K; Kumada H; Yamamoto T; Yoshida F; Sakurai Y; Yamamoto K; Nose T
J Exp Clin Cancer Res; 2005 Mar; 24(1):93-8. PubMed ID: 15943038
[TBL] [Abstract][Full Text] [Related]
4. A theranostic approach based on the use of a dual boron/Gd agent to improve the efficacy of Boron Neutron Capture Therapy in the lung cancer treatment.
Alberti D; Protti N; Toppino A; Deagostino A; Lanzardo S; Bortolussi S; Altieri S; Voena C; Chiarle R; Geninatti Crich S; Aime S
Nanomedicine; 2015 Apr; 11(3):741-50. PubMed ID: 25596074
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of MRI contrast agents in malignant fibrous histiocytoma for gadolinium neutron capture therapy.
Fujimoto T; Ichikawa H; Akisue T; Fujita I; Kishimoto K; Hara H; Imabori M; Kawamitsu H; Sharma P; Brown SC; Moudgil BM; Fujii M; Yamamoto T; Kurosaka M; Fukumori Y
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S355-8. PubMed ID: 19386506
[TBL] [Abstract][Full Text] [Related]
6. A carborane-derivative "click" reaction under heterogeneous conditions for the synthesis of a promising lipophilic MRI/GdBNCT agent.
Toppino A; Bova ME; Geninatti Crich S; Alberti D; Diana E; Barge A; Aime S; Venturello P; Deagostino A
Chemistry; 2013 Jan; 19(2):721-8. PubMed ID: 23154917
[TBL] [Abstract][Full Text] [Related]
7. Insights into the use of gadolinium and gadolinium/boron-based agents in imaging-guided neutron capture therapy applications.
Deagostino A; Protti N; Alberti D; Boggio P; Bortolussi S; Altieri S; Crich SG
Future Med Chem; 2016 May; 8(8):899-917. PubMed ID: 27195428
[TBL] [Abstract][Full Text] [Related]
8. 1H and 10B NMR and MRI investigation of boron- and gadolinium-boron compounds in boron neutron capture therapy.
Bonora M; Corti M; Borsa F; Bortolussi S; Protti N; Santoro D; Stella S; Altieri S; Zonta C; Clerici AM; Cansolino L; Ferrari C; Dionigi P; Porta A; Zanoni G; Vidari G
Appl Radiat Isot; 2011 Dec; 69(12):1702-5. PubMed ID: 21371896
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution and tumor-accumulation of gadolinium (Gd) encapsulated in long-circulating liposomes in tumor-bearing mice for potential neutron capture therapy.
Le UM; Cui Z
Int J Pharm; 2006 Aug; 320(1-2):96-103. PubMed ID: 16713149
[TBL] [Abstract][Full Text] [Related]
10. Boron nanoparticles inhibit tumour growth by boron neutron capture therapy in the murine B16-OVA model.
Petersen MS; Petersen CC; Agger R; Sutmuller M; Jensen MR; Sørensen PG; Mortensen MW; Hansen T; Bjørnholm T; Gundersen HJ; Huiskamp R; Hokland M
Anticancer Res; 2008; 28(2A):571-6. PubMed ID: 18506994
[TBL] [Abstract][Full Text] [Related]
11. Development of a Gadolinium-Boron-Conjugated Albumin for MRI-Guided Neutron Capture Therapy.
Okada S; Nishimura K; Ainaya Q; Shiraishi K; Anufriev SA; Sivaev IB; Sakurai Y; Suzuki M; Yokoyama M; Nakamura H
Mol Pharm; 2023 Dec; 20(12):6311-6318. PubMed ID: 37909734
[TBL] [Abstract][Full Text] [Related]
12. In vivo gadolinium neutron capture therapy using a potentially effective compound (Gd-BOPTA).
Matsumura A; Zhang T; Yamamoto T; Yoshida F; Sakurai Y; Shimojo N; Nose T
Anticancer Res; 2003; 23(3B):2451-6. PubMed ID: 12894527
[TBL] [Abstract][Full Text] [Related]
13. Neutron capture nuclei-containing carbon nanoparticles for destruction of cancer cells.
Hwang KC; Lai PD; Chiang CS; Wang PJ; Yuan CJ
Biomaterials; 2010 Nov; 31(32):8419-25. PubMed ID: 20701966
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of a carborane-containing cholesterol derivative and evaluation as a potential dual agent for MRI/BNCT applications.
Alberti D; Toppino A; Geninatti Crich S; Meraldi C; Prandi C; Protti N; Bortolussi S; Altieri S; Aime S; Deagostino A
Org Biomol Chem; 2014 Apr; 12(15):2457-67. PubMed ID: 24604345
[TBL] [Abstract][Full Text] [Related]
15. Dose estimation in B16 tumour bearing mice for future irradiation in the thermal column of the TRIGA reactor after B/Gd/LDL adduct infusion.
Protti N; Ballarini F; Bortolussi S; Bruschi P; Stella S; Geninatti S; Alberti D; Aime S; Altieri S
Appl Radiat Isot; 2011 Dec; 69(12):1842-5. PubMed ID: 21459587
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy.
Yong JH; Barth RF; Wyzlic IM; Soloway AH; Rotaru JH
Anticancer Res; 1995; 15(5B):2033-8. PubMed ID: 8572598
[TBL] [Abstract][Full Text] [Related]
17. Application of boron-entrapped stealth liposomes to inhibition of growth of tumour cells in the in vivo boron neutron-capture therapy model.
Yanagie H; Maruyama K; Takizawa T; Ishida O; Ogura K; Matsumoto T; Sakurai Y; Kobayashi T; Shinohara A; Rant J; Skvarc J; Ilic R; Kuhne G; Chiba M; Furuya Y; Sugiyama H; Hisa T; Ono K; Kobayashi H; Eriguchi M
Biomed Pharmacother; 2006 Jan; 60(1):43-50. PubMed ID: 16260113
[TBL] [Abstract][Full Text] [Related]
18. Development of MRI-Detectable Boron-Containing Gold Nanoparticle-Encapsulated Biodegradable Polymeric Matrix for Boron Neutron Capture Therapy (BNCT).
Wu CY; Hsieh HH; Chang TY; Lin JJ; Wu CC; Hsu MH; Lin MC; Peng SL
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360814
[TBL] [Abstract][Full Text] [Related]
19. Cellular uptake and in vitro antitumor efficacy of composite liposomes for neutron capture therapy.
Peters T; Grunewald C; Blaickner M; Ziegner M; Schütz C; Iffland D; Hampel G; Nawroth T; Langguth P
Radiat Oncol; 2015 Feb; 10():52. PubMed ID: 25889824
[TBL] [Abstract][Full Text] [Related]
20. Gadolinium neutron capture therapy (GdNCT) of melanoma cells and solid tumors with the magnetic resonance imaging contrast agent Gadobutrol.
Hofmann B; Fischer CO; Lawaczeck R; Platzek J; Semmler W
Invest Radiol; 1999 Feb; 34(2):126-33. PubMed ID: 9951792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
